CV Sciences Inc logo

CV Sciences Inc

$ 0.04 +0.002 (+5.56%) 10:08 PM EST
P/E:
At Loss
P/B:
3.80
Market Cap:
$ 5.70M
Enterprise V:
$ 6.22M
Volume:
198.97K
Avg Vol (2M):
421.94K
Also Trade In:
Volume:
198.97K
Market Cap $:
5.70M
PE Ratio:
At Loss
Avg Vol (2-Month):
421.94K
Enterprise Value $:
6.22M
PB Ratio:
3.80
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures, markets and sells plant-based dietary supplements and hemp-based cannabidiol (CBD). The company sells its products under tradenames, such as PlusCBD, HappyLane, ProCBD, CV Acute and CV Defenese. Its products are sold in a variety of market sectors including nutraceutical, beauty care and specialty foods. The specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.64
Equity-to-Asset 0.09
Debt-to-Equity 1.31
Debt-to-EBITDA -0.15
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.51
Distress
Grey
Safe
Beneish M-Score -7.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -23.8
3-Year Book Growth Rate -53.9
Future 3-5Y Total Revenue Growth Rate -22.37

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.12
9-Day RSI 55.09
14-Day RSI 52.32
6-1 Month Momentum % -19.2
12-1 Month Momentum % -76.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.9
Quick Ratio 0.37
Cash Ratio 0.08
Days Inventory 251.42
Days Sales Outstanding 26.9
Days Payable 72.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.8

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 32.35
Operating Margin % -78.39
Net Margin % -85.28
ROE % -336.17
ROA % -81.19
ROIC % -243.4
ROC (Joel Greenblatt) % -937.23
ROCE % -294.4
Years of Profitability over Past 10-Year 1

Financials

CVSI's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:CVSI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 17.305
EPS (TTM) ($) -0.12
Beta 0.74
Volatility % 124.43
14-Day RSI 52.32
14-Day ATR ($) 0.005136
20-Day SMA ($) 0.036659
12-1 Month Momentum % -76.27
52-Week Range ($) 0.0273 - 0.265
Shares Outstanding (Mil) 150.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CV Sciences Inc Filings

Document Form Filing Date
No Filing Data

CV Sciences Inc Analysis

Share your research

Headlines

See More
No news.